Meet us at Pitti Filati (25. – 27. June 2024) and Première Vision (2. – 4. July 2024)!

Meet us at Pitti Filati (25. – 27. June 2024) and Première Vision (2. – 4. July 2024)!

AMSilk Announces Plans to Scale-up Production

  • Plans to scale-up production capacity by several thousand tons a year and expand production network outside of Europe
  • Dr. Lin Römer steps down as CTO but remains committed to the Company in the role of an advisor

Munich, Germany, [01 July 2022] – AMSilk GmbH (“AMSilk”), a world leader in supplying innovative high-performance bio-based silk materials, today announces plans to scale-up production capacity by several thousand tons a year and expand its production network outside of Europe.

AMSilk’s scalable biotechnological platform and best-in-class patent portfolio means it is able to produce large quantities of premium bio fabricated silk materials in constant quality.

The Company also announces that co-founder and CTO Dr. Lin Römer has stepped down from the management team and Board, and will move to a part-time consultancy role supporting AMSilk with his broad and versatile expertise and know-how.

After 14 years at AMSilk, Dr. Römer has decided to pursue new opportunities outside of the Company. Over the past decade, he has been dedicated to the success and the growth of AMSilk, and he has been instrumental in bringing its biotech products from the lab to industrial scale, resulting in the successful market launch of the world’s first artificial spider silk products.

Dr. Wolfgang Colberg, Chair of the Advisory Board, AMSilk, said: “As AMSilk enters a new phase of growth, we are accelerating our plans for the industrial scale up of production of our innovative high-performance biotech materials. The Board and I would like to thank Lin for his outstanding work over many years. His achievements for AMSilk, which he co-founded and shaped from day one, cannot be overstated. Today, AMSilk is a successful company destined to continue its strong growth course. AMSilk will miss his leadership and strategic skills, extensive experience and deep knowledge.”

Dr. Lin Römer added: “I am proud of what we have achieved since the Company was founded. AMSilk is now well equipped to successfully drive commercial production of its highly sought-after silk materials. I wish AMSilk and its exceptional team every success for the future with its ground-breaking technology in the emerging field of industrial biotechnology.”

In May 2022, Klaus Kjeldal was appointed Chief Production Officer and Managing Director to lead the scale-up of AMSilk’s protein production with existing CMOs.



For further information please contact

AMSilk GmbH

Eric Insel

Tel: +49 (0)89 57 95 393-0



Optimum Strategic Communications

Hollie Vile, Manel Mateus, Vici Rabbetts

Tel: +44 (0) 208 078 4357



About AMSilk

AMSilk GmbH is the world’s first industrial supplier of vegan silk biopolymers and has its headquarters in Munich, Germany. AMSilk’s high-performance biopolymers have the unique functional properties of the natural product they are based on. AMSilk offers its innovative range of high-performance Biosteel® fibers for textiles and industrial applications worldwide and has announced collaborations and partnerships with world leading brands like Adidas and Airbus. The organic high-performance material can be used in multiple ways and is suited for medical devices as well as for personal care products. AMSilk biopolymers give such products unique properties. Among other things, the polymers are biocompatible, safe and robust. AMSilk invites you to discover more at